Tag: iShares U.S. Healthcare Providers ETF

Trump administration finalizes better-than-feared Medicare Advantage payment rate in boost to health insurers

The March jobs report will be released on Friday. Here’s what to expect

Novo Nordisk says Wegovy pill outperforms Lilly’s oral GLP-1 in cross-trial comparison

Thorne is on pace for $650 million in sales as Gen Z fuels a supplement boom — despite subscription fatigue

Stocks soar on hopes of Iran war resolution — plus, Lilly takes a big swing in sleep disorders

U.S. executives, from Apple to Eli Lilly, revamp their push into the world’s second-largest economy at the China Development Forum

Pfizer to seek FDA approval for Lyme disease vaccine candidate despite trial miss

9% of ACA health-care plan enrollees go uninsured after enhanced subsidies expire, poll finds

Healthy Returns: Stopping GLP-1s raises risk of heart attack, stroke and death, study says

FDA approves psoriasis pill from J&J that rivals shots Tremfya, Skyrizi